Several antiresorptive agents have been developed for the treatment of osteoporosis and bone disorders. Few agents have been introduced that stimulate bone formation. Treatment with parathyroid hormone induces, however, a potent increase in hip and lumbar bone mineral density (BMD) and is now available in some countries. The present review focuses on growth hormone (GH) / GH secretagogues (GHSs). GH / GHSs stimulates bone turnover, thereby increasing bone mass and density.
Keywords: growth hormone, growth hormone secretagogue, bone, bone mineral content, bone mineral density
open access plus
Rights & PermissionsPrintExport